Senate Report Highlights Extreme Danger of Illegally-
Imported Fentanyl from China
PSM Commends Year-Long Bipartisan Investigation
Washington, D.C. (January 25, 2018) – The Partnership for Safe Medicines today issued the following statement regarding a new Senate report that highlights the direct harm posed by illegally-imported fentanyl from China:
“There’s no other way to say it: This is an alarming report that reinforces the need to strengthen our defenses against illegal fentanyl that is killing tens of thousands of Americans every year. Despite having the safest drug supply in the world, criminals are taking advantage of every possible delivery mechanism to profit and exacerbate the opioid crisis. It’s essential that we stop them.”
“We must continue to deploy all tools at our disposal to help law enforcement and customs officials prevent illegally-imported fentanyl from entering our borders. At the same time, it’s essential that we leave no stone unturned when it comes to addressing gaps that exist. The recent passage of the INTERDICT Act is a step in the right direction, but we must treat imported fentanyl like the criminal operation that it is.”
“Above all, Congress should resist any effort to legalize importation that will only open the floodgates and lead to more fentanyl in our communities. This report is a timely reminder of what’s at stake if we let our guard down.”
Last year, PSM released an analysis of states that have reported fentanyl-related deaths. For more information and background, click here.
The Partnership for Safe Medicines (PSM) is a public health group comprised of 69 non-profit organizations that are committed to the safety of prescription drugs and protecting consumers against counterfeit, substandard or otherwise unsafe medicines.
Additional information may be found at safemedicines.org | Facebook: facebook.com/SafeMedicines | Twitter: @SafeMedicines | YouTube:youtube.com/user/SafeMedicines.